Collidion Inc.

PETALUMA, CA · Founded 2015 · CIK 0001668476 · Biotech · Private

drug delivery platform using colloidal technology to improve therapeutic bioavailability and targeted delivery

collidion.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$575K
2 Form D · Aug 2019
86 months since last filing
Contracts
—
No federal contracts on record
Patents
38
9 granted · 29 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$300,000
Private capital raisedForm D · SEC$275,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2591SACYL PHARMACEUTICALS, INC.——
2592HELICAL BIOSCIENCES LLC——
2593Dawah Pharmaceuticals, Inc.—$580K
2594Collidion Inc.—$575K
2595Animantis LLC—$550K
2596EVRYS BIO LLC—$548K
2597Nascent Biotech Inc.—$543K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 9 related persons
  • Hojabr AlimiDirector · Executive Officer
  • Gregg AltonDirector · Executive Officer
  • Ettore CarinoDirector
  • Jeffrey CastilloDirector
  • Mark FenlonDirector
  • Gregory FrenchDirector
  • Sameer HarishExecutive Officer
  • Elliot MazaExecutive Officer
  • William WatsonExecutive Officer

Patents

USPTO · 9 granted of 38

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.